Volume 29, Issue 1 (December 2018)
Japanese

Pharmacological treatment for pregnancy and lactation associated osteoporosis. Kitajima Maiko 1 , Chaki Osamu 2 1Department of Obstetrics and Gynecology, Yokohama Rosai hospital, Yokohama, Japan. 2Department of Obstetrics and Gynecology, Yokohama Rosai hospital, Yokohama, Japan. pp.70-76
Published Date 2018/12/28
  • Abstract
  • Look Inside
  • Reference

 Pregnancy and lactation associated osteoporosis(PLO)is a rare disorder for women during pregnancy, the post-partum period, or while breastfeeding. It still remains unknown factors in its pathogenesis. That makes it there is no evident strategy for PLO now.  In most cases, bone mineral density(BMD)of PLO patients spontaneously recovers after giving lactation up. On the other hand, patients with severe cases sometimes need bone specific therapy. There are some reports that show bisphosphonate, teriparatide and/or denosumab are effective on PLO cases. When the patients have wishes for having babies, we have to pay attention if the prescription effect on next pregnancy.



基本情報

09175857.29.1.jpg
CLINICAL CALCIUM
29巻1号 (2018年12月)
電子版ISSN 印刷版ISSN 0917-5857 医薬ジャーナル社

関連文献

もっと見る

文献を共有